Target
Major surface glycoprotein G
Ligand
BDBM195021
Substrate
n/a
Meas. Tech.
Viral Cytopathic Effect (CPE) Assay
Citation
 Gao, LGuo, LLiang, CWang, BWang, LYun, HZhang, WZheng, X Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection US Patent  US9670211 Publication Date 6/6/2017 
Target
Name:
Major surface glycoprotein G
Synonyms:
Attachment glycoprotein G | G | GLYC_HRSV | Membrane-bound glycoprotein | mG
Type:
Protein
Mol. Mass.:
32805.15
Organism:
Human respiratory syncytial virus A (strain Long)
Description:
P20895
Residue:
298
Sequence:
MSKNKDQRTAKTLEKTWDTLNHLLFISSGLYKLNLKSIAQITLSILAMIISTSLIITAIIFIASANHKVTLTTAIIQDATSQIKNTTPTYLTQDPQLGISFSNLSEITSQTTTILASTTPGVKSNLQPTTVKTKNTTTTQTQPSKPTTKQRQNKPPNKPNNDFHFEVFNFVPCSICSNNPTCWAICKRIPNKKPGKKTTTKPTKKPTFKTTKKDLKPQTTKPKEVPTTKPTEEPTINTTKTNITTTLLTNNTTGNPKLTSQMETFHSTSSEGNLSPSQVSTTSEHPSQPSSPPNTTRQ
  
Inhibitor
Name:
BDBM195021
Synonyms:
US9670211, 11
Type:
Small organic molecule
Emp. Form.:
C25H26ClN5O2
Mol. Mass.:
463.959
SMILES:
CC(C)C(=O)N1CC[C@H](C1)n1c(CN2C(=O)C3(CC3)c3ccncc23)nc2cc(Cl)ccc12 |r|
Structure:
Search PDB for entries with ligand similarity: